Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Neurotoxicology. 2012 Jul 6;33(5):1203–1211. doi: 10.1016/j.neuro.2012.06.012

Table 3.

Change in VRAM performance measures according to child demographic and testing factors*

N Latency, seconds (95% CI) Distance, maze units (95% CI) Working Memory Count Ratio (95% CI) Reference Memory Count Ratio (95% CI)
Trial (per trial) 255 −7 (−8, −6) −0.9 (−1.0, −0.8) 0.90 (0.89, 0.91) 0.89 (0.88, 0.91)
Age (per year) 255 −6 (−9, −3) −1.2 (−1.7, −0.6) 0.76 (0.68, 0.85) 0.91 (0.86, 0.97)
Sex
 Girls 126 Ref Ref Ref Ref
 Boys 129 −14 (−20, −9) −1.2 (−2.2, −0.3) 0.81 (0.66, 0.99) 0.88 (0.79, 0.98)
Socioeconomic Status Category
 High 83 Ref Ref Ref Ref
 Medium 101 −2 (−9, 5) 0.0 (−1.1, 1.1) 1.05 (0.82, 1.35) 0.97 (0.85, 1.10)
 Low 54 3 (−5, 11) 1.2 (−0.1, 2.5) 1.25 (0.93, 1.67) 1.06 (0.91, 1.23)
Reported Sensitivity to Motion Sickness
 No 209 Ref Ref Ref Ref
 Yes 46 1 (−7, 8) 0.0 (−1.3, 1.3) 1.06 (0.81, 1.39) 1.02 (0.88, 1.17)
Dizziness During Testing
 No 235 Ref Ref Ref Ref
 Yes 20 20 (8, 32) 2.1 (0.1, 4.1) 1.57 (1.08, 2.30) 1.17 (0.95, 1.44)
Visual Deficits
 None 181 Ref Ref Ref Ref
 Astigmatism 21 0 (−10, 11) −0.3 (−2.1, 1.5) 1.01 (0.69, 1.47) 0.95 (0.78, 1.16)
 Myopia 32 −1 (−10, 8) 0.1 (−1.4, 1.5) 0.94 (0.68, 1.28) 0.99 (0.84, 1.17)
 Both 12 −1 (−14, 13) 0.2 (−2.1, 2.5) 1.04 (0.64, 1.70) 0.92 (0.71, 1.19)
 Other 9 −13 (−28, 3) −2.6 (−5.2, 0.0) 0.43 (0.24, 0.79) 0.73 (0.54, 1.00)
 Any 74 −1 (−4, 1) −0.2 (−0.7, 0.2) 0.92 (0.84, 1.01) 0.96 (0.91, 1.01)
*

-All models are adjusted for trial.

-Count ratios represent the fold-difference in the number of working or reference memory errors relative to the reference group. Ratios >1 indicate more errors, while ratios <1 indicate less errors.

-Bolded estimates are statistically significant (p<0.05). Null values for latency and distance are 0 and 1.0 for working memory and reference memory errors.